This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Marjolin's ulcer

Authoring team

A Marjolin's ulcer (MU) is a cutaneous malignant transformation seen after long term inflammatory or traumatic insult to the skin.

  • MU mostly arises in an area of chronic burn wounds. They are also seen in areas of chronic inflammation such as non-healing wounds, venous ulcers, lupus vulgaris, vaccination scars, snake bite scars, pressure sores, osteomyelitis zones, pilonidal abscess, and radiotherapy area
  • the term Marjolin's ulcer (MU) has been used synonymously with burn scar carcinoma
  • squamous cell carcinoma (SCC) is the most common cell type reported in MU
    • other cancers have also been observed as MU e.g. - basal cell carcinoma and malignant melanoma
  • when compared to primary cutaneous cancers, they are more aggressive and have higher rates of local recurrence and metastasis (1,2)

The condition was first described in 1828 by the French surgeon Jean Nicolas Marjolin.

  • he described the cellular changes of ulcerated lesions in scar tissue
  • however a detailed description of the pathology was published by Robert Smith in 1850 and the condition was named “Marjolin’s ulcer” (1)

It is characterised by:

  • slow growth - the scar is relatively avascular
  • painless - the scar is devoid of nerve fibres
  • absence of secondary deposits in regional lymph nodes - as the lymphatics have been destroyed. However, if the ulcer invades normal tissue surrounding the scar, it will advance at normal rates and most likely involve lymphatics

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.